TECH

Bio-Techne Corporation

Price

$72.62

return (12m)

14.60%

p/e

62.26

p/bv

5.37

DIVIDEND YIELD

0.44%

TECH price

Bio-Techne

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment TECH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.12%

3 months

1.61%

1 year

14.60%

2 years

5.08%

5 years

-41.76%

10 years

199.92%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals TECH

Valuation

P/E

62.26

Sector -3.10

Industry -3.10

P/BV

5.37

Sector 1.77

Industry 1.77

P/Revenue (PSR)

9.32

Sector 2.01

Industry 2.01

EV/EBITDA

116.13

Sector -216.09

Industry -216.09

EV/EBIT

154.63

Sector -45.33

Industry -45.33

P/EBITDA

32.57

Sector -21.53

Industry -21.53

P/EBIT

45.23

Sector -26.64

Industry -26.64

P/Total Assets

4.38

Sector 1.05

Industry 1.05

P/Net Current Assets

42.58

Sector -9.24

Industry -9.24

P/Working Capital

19.50

Sector -136.79

Industry -136.79

EPS

1.16

Sector -1.78

Industry -1.78

BVPS

13.49

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

65.77%

Sector 41.24%

Industry 41.24%

EBITDA Margin

30.18%

Sector -20,889.63%

Industry -20,889.63%

EBIT Margin

20.73%

Sector -35.37%

Industry -35.37%

Net Profit Margins

14.97%

Sector -35.81%

Industry -35.81%

Asset Turnover

0.12

Sector 0.03

Industry 0.03

Profitability

ROE

8.63%

Sector -57.47%

Industry -57.47%

ROA

7.03%

Sector -59.48%

Industry -59.48%

ROIC

13.18%

Sector -2,385.22%

Industry -2,385.22%

Dividends

Dividend yield

0.44%

Sector -

Industry -

Payout

27.39%

Sector -

Industry -

Debt

Current Ratio

4.55

Sector 2.92

Industry 2.92

Net Debt / EBITDA

-0.67

Sector -21.89

Industry -21.89

Net Debt / EBIT

-0.89

Sector -8.32

Industry -8.32

Net Debt / Equity

-0.03

Sector -33,113.00

Industry -33,113.00

Gross Debt / Equity

0.09

Sector -0.84

Industry -0.84

Equity/Assets

0.82

Sector 0.46

Industry 0.46

Liabilities/Assets

0.18

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

3.37%

Sector -

Industry -

5Y Earnings CAGR

-2.89%

Sector -

Industry -

Fundamentals TECH

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Bio-Techne ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$72.62

Fair Value

$18.76

Upside

-74.16%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TECH Bio-Techne Corporation	$72.62	15.20%	0.44%	62.26	5.37	8.63%	14.97%
PFE Pfizer Inc.	$30.42	33.08%	5.91%	38.29	1.94	5.07%	6.80%
ABBV AbbVie Inc.	$285.19	27.18%	2.41%	79.37	-84.48	-106.44%	9.81%
NVO Novo Nordisk A/S	$39.43	-22.23%	4.74%	9.57	5.08	53.11%	35.32%
MRK Merck & Co. Inc.	$147.24	72.97%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$172.57	5.24%	1.95%	19.76	5.09	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.00	49.69%	4.19%	13.18	5.48	41.59%	18.87%
ZTS Zoetis Inc.	$82.00	-42.79%	2.64%	12.52	10.49	83.77%	27.69%
AMGN Amgen Inc.	$447.28	52.62%	2.29%	26.86	20.10	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$819.09	42.84%	0.47%	18.88	2.58	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$124.54	86.21%	0.00%	34.40	99.12	288.13%	24.86%
MCK McKesson Corporation	$1,012.09	29.06%	0.34%	25.91	-30.79	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$535.17	25.55%	0.00%	29.00	6.31	21.76%	35.00%
CAH Cardinal Health Inc.	$255.64	62.63%	0.81%	34.89	-21.95	-62.92%	0.67%
ARGX argenx SE	$874.71	4.79%	0.00%	14.93	3.96	26.52%	25.54%
HRMY Harmony Biosciences Holdings Inc.	$36.03	37.73%	0.00%	12.22	2.22	18.14%	18.88%
UTHR United Therapeutics Corporation	$584.79	38.40%	0.00%	17.50	3.58	20.48%	41.56%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TECH - Historical Dividends

Current Dividend Yield

0.44%

5-year average Dividend Yield

0.41%

Current Payout

27.39%

5-year average Payout

32.42%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	08/21/2026	08/28/2026	0.08000000
Dividends	08/14/2026	08/28/2026	0.08000000
Dividends	05/15/2026	05/29/2026	0.08000000
Dividends	02/13/2026	02/27/2026	0.08000000
Dividends	11/14/2025	11/28/2025	0.08000000
Dividends	08/15/2025	08/29/2025	0.08000000
Dividends	05/16/2025	05/30/2025	0.08000000
Dividends	02/14/2025	02/28/2025	0.08000000
Dividends	11/08/2024	11/22/2024	0.08000000
Dividends	08/16/2024	08/30/2024	0.08000000
Dividends	05/09/2024	05/24/2024	0.08000000
Dividends	02/08/2024	02/26/2024	0.08000000
Dividends	11/08/2023	11/24/2023	0.08000000
Dividends	08/16/2023	09/01/2023	0.08000000
Dividends	05/11/2023	05/26/2023	0.08000000
Dividends	02/09/2023	02/27/2023	0.08000000
Dividends	11/10/2022	11/28/2022	0.08000000
Dividends	08/11/2022	08/29/2022	0.08000000
Dividends	05/12/2022	05/27/2022	0.08000000
Dividends	02/09/2022	02/25/2022	0.08000000
Dividends	11/10/2021	11/26/2021	0.08000000
Dividends	08/12/2021	08/27/2021	0.08000000
Dividends	05/13/2021	05/28/2021	0.08000000
Dividends	02/10/2021	02/26/2021	0.08000000
Dividends	11/12/2020	11/27/2020	0.08000000
Dividends	08/14/2020	08/28/2020	0.08000000
Dividends	05/07/2020	05/22/2020	0.08000000
Dividends	02/12/2020	02/28/2020	0.08000000
Dividends	11/06/2019	11/22/2019	0.08000000
Dividends	08/14/2019	08/30/2019	0.08000000
Dividends	05/08/2019	05/24/2019	0.08000000
Dividends	02/13/2019	03/01/2019	0.08000000
Dividends	11/07/2018	11/23/2018	0.08000000
Dividends	08/15/2018	08/31/2018	0.08000000
Dividends	05/10/2018	05/25/2018	0.08000000
Dividends	02/14/2018	03/02/2018	0.08000000
Dividends	11/08/2017	11/24/2017	0.08000000
Dividends	08/16/2017	09/01/2017	0.08000000
Dividends	05/17/2017	06/02/2017	0.08000000
Dividends	02/15/2017	03/03/2017	0.08000000
Dividends	11/10/2016	11/28/2016	0.08000000
Dividends	08/25/2016	09/12/2016	0.08000000
Dividends	05/11/2016	05/27/2016	0.08000000
Dividends	02/10/2016	02/26/2016	0.08000000
Dividends	11/11/2015	11/27/2015	0.08000000
Dividends	08/13/2015	08/28/2015	0.08000000
Dividends	05/13/2015	05/29/2015	0.08000000
Dividends	02/11/2015	02/27/2015	0.08000000
Dividends	11/06/2014	11/24/2014	0.08000000
Dividends	08/19/2014	08/29/2014	0.07750000
Dividends	05/07/2014	05/23/2014	0.07750000
Dividends	02/12/2014	02/28/2014	0.07750000
Dividends	11/08/2013	11/25/2013	0.07750000
Dividends	08/14/2013	08/30/2013	0.07500000
Dividends	05/08/2013	05/24/2013	0.07500000
Dividends	02/13/2013	03/01/2013	0.07500000
Dividends	11/01/2012	11/19/2012	0.07500000
Dividends	08/08/2012	08/24/2012	0.07000000
Dividends	05/09/2012	05/25/2012	0.07000000
Dividends	02/08/2012	02/24/2012	0.07000000
Dividends	11/03/2011	11/21/2011	0.07000000
Dividends	08/10/2011	08/26/2011	0.06750000
Dividends	05/11/2011	05/27/2011	0.06750000
Dividends	02/09/2011	02/28/2011	0.06750000
Dividends	11/04/2010	11/22/2010	0.06750000
Dividends	08/12/2010	08/31/2010	0.06500000
Dividends	05/12/2010	05/28/2010	0.06500000
Dividends	02/10/2010	02/26/2010	0.06500000
Dividends	11/05/2009	11/23/2009	0.06500000
Dividends	08/13/2009	08/31/2009	0.06250000
Dividends	05/06/2009	05/22/2009	0.06250000
Dividends	02/11/2009	02/27/2009	0.06250000
Dividends	10/30/2008	11/17/2008	0.06250000

ABOUT Bio-Techne

Bio-Techne Corporation

Average Investor10 user rating

4.0 (2 people)

United States

50 years

Founded: 1976

1992

Time since IPO - 34 years

2.300

Employees

Bio-Techne Corporation (United States) is listed on the Nasdaq and has a market capitalization of $11.32 billion, with shareholders equity totaling $2.11 billion.

The company employs approximately 2.300 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Bio-Techne Corporation reported $1.22 billion in revenue, generating net income of $181.86 million.

Key financial metrics include a P/E ratio of 62.26, a price-to-book (P/B) ratio of 5.37, and a trailing twelve-month dividend yield of 0.44%.

The company trades under the ticker TECH.

Market cap

$11.32 billion

Net worth

$2.11 billion

$2,108,221,000.00

Assets

$2.59 billion

$2,586,726,000.00

Total Shares Outstanding

156.22 million

156,224,000

Average Daily Trading Volume

$2.83 million

$2,828,508.24

Sector

Health Care

Industry

Biotechnology

TECH

TECH revenue and profits

Financial Results TECH

DRAG THE FRAME TO SEE MORE DATA

TECH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,012.09 28,13% (12M)

P/E

25.91

0.34%

ROE

-118.84%

P/BV

-30.79

CAH - Cardinal Health

$255.64 62,14% (12M)

P/E

34.89

0.81%

ROE

-62.92%

P/BV

-21.95

ABBV - AbbVie

$285.19 28,93% (12M)

P/E

79.37

2.41%

ROE

-106.44%

P/BV

-84.48

MRK - Merck & Co.

$147.24 73,85% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$172.57 5,38% (12M)

P/E

19.76

1.95%

ROE

25.77%

P/BV

5.09

PFE - Pfizer

$30.42 34,05% (12M)

P/E

38.29

5.91%

ROE

5.07%

P/BV

1.94

BMY - Bristol-Myers Squibb

$63.00 52,11% (12M)

P/E

13.18

4.19%

ROE

41.59%

P/BV

5.48

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,012.09 28,13% (12 M)

P/L

25.91

0.34%

ROE

-118.84%

P/VP

-30.79

CAH - Cardinal Health

$255.64 62,14% (12 M)

P/L

34.89

0.81%

ROE

-62.92%

P/VP

-21.95

ABBV - AbbVie

$285.19 28,93% (12 M)

P/L

79.37

2.41%

ROE

-106.44%

P/VP

-84.48

MRK - Merck & Co.

$147.24 73,85% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$172.57 5,38% (12 M)

P/L

19.76

1.95%

ROE

25.77%

P/VP

5.09

PFE - Pfizer

$30.42 34,05% (12 M)

P/L

38.29

5.91%

ROE

5.07%

P/VP

1.94

BMY - Bristol-Myers Squibb

$63.00 52,11% (12 M)

P/L

13.18

4.19%

ROE

41.59%

P/VP

5.48

Frequently Asked Questions

What is the price of Bio-Techne (TECH) today?

The current price of Bio-Techne (TECH) is $72.62. The stock began the year trading around $58.81 and is currently priced at $72.62. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Bio-Techne (TECH) pay dividends?

Bio-Techne (TECH) distributed dividends in the last year, in the months of February, May and August totaling $0.32. The Dividend Yield for the last 12 months is 0.44%.

Is Bio-Techne (TECH) a good investment?

Bio-Techne (TECH) is currently trading at $72.62 with a P/E ratio of 62.26. This represents a 6,980% premium compared to its historical average P/E. Over the past year, the stock paid $0.32 in dividends, resulting in a dividend yield of 0.44%. The total shareholder return over the same period was 14.60%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Bio-Techne (TECH) stock?

You can buy Bio-Techne (TECH) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol TECH and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Bio-Techne (TECH) yield today?

Over the past month, Bio-Techne (TECH) has returned 0.12% — 14.60% over the past year, and -41.76% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.40 per share in dividends, resulting in a dividend yield of 0.44%.

If you were to purchase 100 shares of Bio-Techne (TECH) today at the current price of $72.62 your total investment would be $7,262.00.

Based on historical performance, the investment would have grown to approximately:

$8,322.25 after 1 year
$4,229.39 after 5 years
$21,780.19 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

TECH

Bio-Techne Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment TECH

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING TECH WITH OTHER STOCKS

type

Ex - Dividend Date

payment date

value

ABOUT Bio-Techne

Bio-Techne Corporation

United States

50 years

1992

2.300

PROFIT X PRICE TECH

Financial Results TECH

TECH cash flow

Asset, Revenue and Profit Growth - TECH

TECH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions